nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00667	0.00667	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00652	0.00653	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00638	0.00638	CbGpPWpGaD
Nebivolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00558	0.00558	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00556	0.00556	CbGpPWpGaD
Nebivolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00546	0.00546	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00544	0.00544	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00532	0.00532	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00487	0.00487	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00467	0.00467	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00457	0.00457	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00447	0.00447	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00381	0.00381	CbGpPWpGaD
Nebivolol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0037	0.0037	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0037	0.0037	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00327	0.00327	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00317	0.00317	CbGpPWpGaD
Nebivolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00314	0.00314	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00313	0.00313	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00308	0.00308	CbGpPWpGaD
Nebivolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00307	0.00307	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00304	0.00304	CbGpPWpGaD
Nebivolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00304	0.00304	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00303	0.00303	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00301	0.00302	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00297	0.00297	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00295	0.00295	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00271	0.00272	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00269	0.00269	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00266	0.00266	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00266	0.00266	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0026	0.0026	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0026	0.0026	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00254	0.00254	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.0025	0.0025	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.0025	0.0025	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00241	0.00242	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00222	0.00222	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00215	0.00215	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0021	0.00211	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00207	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00206	0.00206	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00203	0.00203	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00202	0.00202	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00198	0.00198	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00198	0.00198	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00194	0.00194	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00194	0.00194	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00184	0.00184	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00184	0.00184	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0018	0.0018	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0018	0.0018	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00176	0.00176	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00175	0.00175	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00175	0.00175	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00172	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00171	0.00171	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0017	0.0017	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
Nebivolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00168	0.00168	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00167	0.00167	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00167	0.00167	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00166	0.00166	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00166	0.00166	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00164	0.00164	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00163	0.00163	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00162	0.00162	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00159	0.00159	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00158	0.00158	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00158	0.00158	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00158	0.00158	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00157	0.00157	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00155	0.00155	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00154	0.00154	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00153	0.00153	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00153	0.00153	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00151	0.00151	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00147	0.00147	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00146	0.00147	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00145	0.00145	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00143	0.00143	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00143	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00142	0.00142	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00141	0.00141	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0014	0.0014	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.0014	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00138	0.00138	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00137	0.00137	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00136	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00135	0.00135	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00134	0.00134	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00131	0.00131	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00128	0.00128	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00125	0.00126	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00123	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00117	0.00117	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00117	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00114	0.00114	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.00114	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00114	0.00114	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0011	0.00111	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00109	0.00109	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00109	0.00109	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00109	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00108	0.00108	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00107	0.00107	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00107	0.00107	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.00106	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.00106	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00106	0.00106	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00105	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00105	0.00105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00104	0.00104	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00104	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00104	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00103	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00103	0.00103	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00102	0.00102	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00101	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000999	0.000999	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000994	0.000994	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000977	0.000978	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000956	0.000956	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000934	0.000935	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000919	0.000919	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000914	0.000914	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000899	0.000899	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000898	0.000898	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000894	0.000894	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000891	0.000892	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000885	0.000886	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000879	0.000879	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000813	0.000813	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000793	0.000793	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000776	0.000776	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000759	0.000759	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000729	0.00073	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00072	0.000721	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000713	0.000714	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000705	0.000705	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0007	0.0007	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000698	0.000698	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000693	0.000694	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000689	0.000689	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000684	0.000685	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000678	0.000678	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000669	0.000669	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000663	0.000663	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000645	0.000645	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000631	0.000631	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00063	0.00063	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000627	0.000627	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000624	0.000624	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000617	0.000617	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000616	0.000616	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000614	0.000614	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000614	0.000614	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000613	0.000613	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000611	0.000611	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000606	0.000606	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000602	0.000602	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000602	0.000602	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000601	0.000601	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0006	0.0006	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000599	0.0006	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000597	0.000597	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000593	0.000593	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000589	0.000589	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000587	0.000587	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000587	0.000587	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000585	0.000586	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00058	0.00058	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000576	0.000576	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000573	0.000573	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000567	0.000567	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000565	0.000565	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00056	0.00056	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000557	0.000557	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000555	0.000555	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000552	0.000552	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00055	0.000551	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000545	0.000545	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000542	0.000542	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00054	0.00054	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000538	0.000539	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000533	0.000533	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000526	0.000527	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000513	0.000513	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000502	0.000502	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00049	0.000491	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000426	0.000426	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000416	0.000416	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000407	0.000407	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000395	0.000396	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000387	0.000387	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000378	0.000378	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000372	0.000372	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000367	0.000367	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000364	0.000364	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000359	0.000359	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000356	0.000356	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000351	0.000351	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000346	0.000346	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000343	0.000344	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000338	0.000338	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000335	0.000335	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000331	0.000331	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000329	0.000329	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000328	0.000328	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000325	0.000325	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000322	0.000322	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00032	0.00032	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000318	0.000318	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000315	0.000315	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000311	0.000311	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000303	0.000303	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000296	0.000296	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00029	0.00029	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000253	0.000253	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000253	0.000253	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000249	0.000249	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000232	0.000232	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000212	0.000212	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000208	0.000208	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000203	0.000203	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000203	0.000203	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000193	0.000193	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000154	0.000154	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000152	0.000152	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000112	0.000112	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00011	0.00011	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000107	0.000108	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	6.58e-05	6.59e-05	CbGpPWpGaD
Nebivolol—ADRB1—forebrain—attention deficit hyperactivity disorder	3.49e-05	0.117	CbGeAlD
Nebivolol—HTR1A—forebrain—attention deficit hyperactivity disorder	3e-05	0.1	CbGeAlD
Nebivolol—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	2.95e-05	0.0986	CbGeAlD
Nebivolol—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	2.53e-05	0.0846	CbGeAlD
Nebivolol—HTR1A—midbrain—attention deficit hyperactivity disorder	1.98e-05	0.066	CbGeAlD
Nebivolol—ADRB1—nervous system—attention deficit hyperactivity disorder	1.9e-05	0.0633	CbGeAlD
Nebivolol—ADRB1—central nervous system—attention deficit hyperactivity disorder	1.83e-05	0.0609	CbGeAlD
Nebivolol—CYP2D6—forebrain—attention deficit hyperactivity disorder	1.63e-05	0.0543	CbGeAlD
Nebivolol—HTR1A—nervous system—attention deficit hyperactivity disorder	1.63e-05	0.0543	CbGeAlD
Nebivolol—HTR1A—central nervous system—attention deficit hyperactivity disorder	1.57e-05	0.0523	CbGeAlD
Nebivolol—HTR1A—cerebellum—attention deficit hyperactivity disorder	1.53e-05	0.0511	CbGeAlD
Nebivolol—ADRB1—brain—attention deficit hyperactivity disorder	1.45e-05	0.0484	CbGeAlD
Nebivolol—HTR1A—brain—attention deficit hyperactivity disorder	1.24e-05	0.0415	CbGeAlD
Nebivolol—CYP2D6—nervous system—attention deficit hyperactivity disorder	8.83e-06	0.0295	CbGeAlD
Nebivolol—CYP2D6—central nervous system—attention deficit hyperactivity disorder	8.5e-06	0.0284	CbGeAlD
Nebivolol—CYP2D6—cerebellum—attention deficit hyperactivity disorder	8.31e-06	0.0277	CbGeAlD
Nebivolol—CYP2D6—brain—attention deficit hyperactivity disorder	6.75e-06	0.0225	CbGeAlD
